File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: GnRH regulates trophoblast invasion via RUNX2-mediated MMP2/9 expression

TitleGnRH regulates trophoblast invasion via RUNX2-mediated MMP2/9 expression
Authors
KeywordsGnRH
Invasion
MMP
RUNX2
Trophoblast
Issue Date2015
Citation
Molecular Human Reproduction, 2015, v. 22, n. 2, p. 119-129 How to Cite?
AbstractStudy hypothesis: We hypothesized that Runt-related transcription factor 2 (RUNX2), matrix metalloproteinase (MMP)2 and MMP9 are involved in basal and gonadotrophin-releasing hormone (GnRH)-induced human extravillous trophoblast (EVT) cell invasion. studyfinding: Our finding indicates that GnRH-induced RUNX2 expression enhances the invasive capacity of EVT cells by modulating the expression of MMP2 and MMP9. what is known already: GnRH is expressed in first-trimester placenta and exerts pro-invasive effects on EVT cells in vitro. RUNX2 regulates MMP2 and MMP9 expression and is often associated with invasive phenotypes. study design, samples/materials, methods: First-trimesterhuman placenta (n 1/4 9) was obtained fromwomenundergoing elective termination of pregnancy. The localization of RUNX2, MMP2 and MMP9 in first-trimester human placenta was examined by immunohistochemistry. Primary or immortalized (HTR-8/SVneo) EVT cells were treated alone or in combination with GnRH, GnRH antagonist Antide, MAPK kinase inhibitor PD98095, phosphatidylinositol 3-kinase inhibitor LY294002, MMP2/9 inhibitor or small interfering RNAs (siRNAs) targeting RUNX2, MMP2 and/or MMP9. Protein and mRNA levels were measured by western blot and RT-PCR, respectively. Cell invasiveness was evaluated by transwell Matrigel or collagen I invasion assays. main results and the role of chance: RUNX2, MMP2 and MMP9 were detected in the cell column regions of human firsttrimester placental villi. GnRH treatment increased RUNX2 mRNA and protein levels in HTR-8/SVneo cells and primary EVTs, and these effects were attenuated by co-treatment with Antide, PD98095 or LY294002. Down-regulation of RUNX2 by siRNA reduced basal and GnRH-induced MMP2/9 expression and cell invasion. Moreover, pharmacological inhibition or siRNA-mediated knockdown of MMP2/9 reduced basal and GnRH-induced cell invasion. limitations, reasons for caution: The lack of an in vivo model is the major limitation of our in vitro study. wider implications of the findings: Our findings provide important insight into the functions of the GnRH - GnRH receptor system in early implantation and placentation. large scale data: Not applicable. study funding and competing interest(s): This research was supported by Canadian Institutes of Health Research (Grant #143317) to P.C.K.L. The authors have nothing to disclose.
Persistent Identifierhttp://hdl.handle.net/10722/355336
ISSN
2023 Impact Factor: 3.6
2023 SCImago Journal Rankings: 1.201
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorPeng, Bo-
dc.contributor.authorZhu, Hua-
dc.contributor.authorKlausen, Christian-
dc.contributor.authorMa, Liyang-
dc.contributor.authorWang, Yan Ling-
dc.contributor.authorLeung, Peter C.K.-
dc.date.accessioned2025-04-03T02:00:07Z-
dc.date.available2025-04-03T02:00:07Z-
dc.date.issued2015-
dc.identifier.citationMolecular Human Reproduction, 2015, v. 22, n. 2, p. 119-129-
dc.identifier.issn1360-9947-
dc.identifier.urihttp://hdl.handle.net/10722/355336-
dc.description.abstractStudy hypothesis: We hypothesized that Runt-related transcription factor 2 (RUNX2), matrix metalloproteinase (MMP)2 and MMP9 are involved in basal and gonadotrophin-releasing hormone (GnRH)-induced human extravillous trophoblast (EVT) cell invasion. studyfinding: Our finding indicates that GnRH-induced RUNX2 expression enhances the invasive capacity of EVT cells by modulating the expression of MMP2 and MMP9. what is known already: GnRH is expressed in first-trimester placenta and exerts pro-invasive effects on EVT cells in vitro. RUNX2 regulates MMP2 and MMP9 expression and is often associated with invasive phenotypes. study design, samples/materials, methods: First-trimesterhuman placenta (n 1/4 9) was obtained fromwomenundergoing elective termination of pregnancy. The localization of RUNX2, MMP2 and MMP9 in first-trimester human placenta was examined by immunohistochemistry. Primary or immortalized (HTR-8/SVneo) EVT cells were treated alone or in combination with GnRH, GnRH antagonist Antide, MAPK kinase inhibitor PD98095, phosphatidylinositol 3-kinase inhibitor LY294002, MMP2/9 inhibitor or small interfering RNAs (siRNAs) targeting RUNX2, MMP2 and/or MMP9. Protein and mRNA levels were measured by western blot and RT-PCR, respectively. Cell invasiveness was evaluated by transwell Matrigel or collagen I invasion assays. main results and the role of chance: RUNX2, MMP2 and MMP9 were detected in the cell column regions of human firsttrimester placental villi. GnRH treatment increased RUNX2 mRNA and protein levels in HTR-8/SVneo cells and primary EVTs, and these effects were attenuated by co-treatment with Antide, PD98095 or LY294002. Down-regulation of RUNX2 by siRNA reduced basal and GnRH-induced MMP2/9 expression and cell invasion. Moreover, pharmacological inhibition or siRNA-mediated knockdown of MMP2/9 reduced basal and GnRH-induced cell invasion. limitations, reasons for caution: The lack of an in vivo model is the major limitation of our in vitro study. wider implications of the findings: Our findings provide important insight into the functions of the GnRH - GnRH receptor system in early implantation and placentation. large scale data: Not applicable. study funding and competing interest(s): This research was supported by Canadian Institutes of Health Research (Grant #143317) to P.C.K.L. The authors have nothing to disclose.-
dc.languageeng-
dc.relation.ispartofMolecular Human Reproduction-
dc.subjectGnRH-
dc.subjectInvasion-
dc.subjectMMP-
dc.subjectRUNX2-
dc.subjectTrophoblast-
dc.titleGnRH regulates trophoblast invasion via RUNX2-mediated MMP2/9 expression-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1093/molehr/gav070-
dc.identifier.pmid26660506-
dc.identifier.scopuseid_2-s2.0-84961588245-
dc.identifier.volume22-
dc.identifier.issue2-
dc.identifier.spage119-
dc.identifier.epage129-
dc.identifier.eissn1460-2407-
dc.identifier.isiWOS:000371183800005-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats